Port RE - Search Results

1

Investigations in vivo of the effects of carbogen breathing on 5-fluorouracil pharmacokinetics and physiology of solid rodent tumours.

McSheehy PM, Port RE, Rodrigues LM, Robinson SP, Stubbs M, van der Borns K, Peters GJ, Judson IR, Leach MO, Griffiths JR. McSheehy PM, et al. Among authors: port re. Cancer Chemother Pharmacol. 2005 Feb;55(2):117-28. doi: 10.1007/s00280-004-0851-9. Epub 2004 Oct 5. Cancer Chemother Pharmacol. 2005. PMID: 15592719

2

Local disposition kinetics of floxuridine after intratumoral and subcutaneous injection as monitored by [19F]-nuclear magnetic resonance spectroscopy in vivo.

Port R, Hanisch F, Becker M, Bachert P, Zeller J. Port R, et al. Cancer Chemother Pharmacol. 1999;44(1):65-73. doi: 10.1007/s002800050946. Cancer Chemother Pharmacol. 1999. PMID: 10367751

3

Simultaneous sustained release of fludarabine monophosphate and Gd-DTPA from an interstitial liposome depot in rats: potential for indirect monitoring of drug release by magnetic resonance imaging.

Port RE, Schuster C, Port CR, Bachert P. Port RE, et al. Cancer Chemother Pharmacol. 2006 Nov;58(5):607-17. doi: 10.1007/s00280-006-0208-7. Epub 2006 Feb 28. Cancer Chemother Pharmacol. 2006. PMID: 16506037

4

Pharmacokinetics and whole-body distribution of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard and its effects on the incorporation of [methyl-3H]-thymidine in various tissues of the rat.

Stüben J, Port R, Bertram B, Bollow U, Hull WE, Schaper M, Pohl J, Wiessler M. Stüben J, et al. Cancer Chemother Pharmacol. 1996;38(4):355-65. doi: 10.1007/s002800050495. Cancer Chemother Pharmacol. 1996. PMID: 8674159

5

Conditions of drug delivery within solid tumors, and noninvasive methods for studies in humans.

Port RE. Port RE. Int J Clin Pharmacol Ther. 1997 Feb;35(2):78-9. Int J Clin Pharmacol Ther. 1997. PMID: 9147714 Review. No abstract available.

6

Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment.

Hull WE, Port RE, Herrmann R, Britsch B, Kunz W. Hull WE, et al. Among authors: port re. Cancer Res. 1988 Mar 15;48(6):1680-8. Cancer Res. 1988. PMID: 3125967

7

Chain-fluorinated polyamines as tumour markers. III. Determination of geminal difluoropolyamines and their precursor 2,2-difluoroputrescine in normal tissues and experimental tumours by in vitro and in vivo 19F NMR spectroscopy.

Hull WE, Kunz W, Port RE, Seiler N. Hull WE, et al. Among authors: port re. NMR Biomed. 1988 Feb;1(1):11-9. doi: 10.1002/nbm.1940010104. NMR Biomed. 1988. PMID: 3275019

8

Pharmacokinetic analysis of sparse in vivo NMR spectroscopy data using relative parameters and the population approach.

Port RE, Schlemmer HP, Bachert P. Port RE, et al. Eur J Clin Pharmacol. 1994;47(2):187-93. doi: 10.1007/BF00194971. Eur J Clin Pharmacol. 1994. PMID: 7859808

9

Contrast-enhanced MR imaging in the indirect monitoring of drug release from an interstitial depot.

Port RE, Schuster C, Port CR, Bachert P. Port RE, et al. Among authors: port cr. Int J Clin Pharmacol Ther. 2005 Dec;43(12):605-6. doi: 10.5414/cpp43605. Int J Clin Pharmacol Ther. 2005. PMID: 16372536 No abstract available.

10

Monitoring local disposition kinetics of carboplatin in vivo after subcutaneous injection in rats by means of 195Pt NMR.

Becker M, Port RE, Zabel HJ, Zeller WJ, Bachert P. Becker M, et al. Among authors: port re. J Magn Reson. 1998 Jul;133(1):115-22. doi: 10.1006/jmre.1998.1436. J Magn Reson. 1998. PMID: 9654475

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters